 | Up a level |
Mehrazmay, A. and Alavian, S.-M. and Moradi-Lakeh, M. and Payam, M.M. and Hashemi-Meshkini, A. and Behnava, B. and Miri, S.M. and Elizeh, P.K. and Tabatabaee, S.V. and Keshvari, M. and Lankarani, K.B. (2013) Cost-effectiveness analysis of adding low dose ribavirin to peginterferon alfa-2a for treatment of chronic hepatitis C infected thalassemia major patients in Iran. Hepatitis Monthly, 13 (9).
Alavian, S.-M. and Mirahmadizadeh, A. and Javanbakht, M. and Keshtkaran, A. and Heidari, A. and Mashayekhi, A. and Salimi, S. and Hadian, M. (2013) Effectiveness of methadone maintenance treatment in prevention of hepatitis C virus transmission among injecting drug users. Hepatitis Monthly, 13 (8). p. 9.
Alavian, S.-M. and Kabir, A. and Ahmadi, A.B. and Lankarani, K.B. and Shahbabaie, M.A. and Ahmadzad-Asl, M. (2010) Hepatitis C infection in hemodialysis patients in Iran: A systematic review. Hemodialysis International, 14 (3). pp. 253-262.
Hajilooi, M. and Alizadeh, A.-H.M. and Ranjbar, M. and Fallahian, F. and Alavian, S.-M. (2007) E-selectin gene polymorphisms in Iranian chronic hepatitis B patients. Hepatitis Monthly, 7 (4). pp. 211-216.
Alavian, S.-M. and Keyvani, H. and Rezai, M. and Ashayeri, N. and Sadeghi, H.M. (2006) Preliminary report of hepatitis B virus genotype prevalence in Iran. World Journal of Gastroenterology, 12 (32). pp. 5211-5213.
